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Complementary and alternative medicine (CAM) is a group of products and services that are not considered part 
of conventional western healthcare practice. Complementary and alternative medicine includes hypnosis, 
acupuncture, aromatherapy, chiropractic care, and the use of herbs and supplements. The National Institutes of 
Health includes a subarea devoted to CAM: the National Center for Complementary and Alternative Medicine, 
which monitors the use of CAM therapies and promotes research on their safety and effectiveness. The goal is 
evidence-based information that can be shared with consumers to assist them in making informed 
decisions.1 According to National Center for Complementary and Alternative Medicine, in 2007, Americans spent 
nearly 11.2% of their total out-of-pocket expenditures,1 with 38% of adults and 17% of children using some form 
of CAM. 
COMPLEMENTARY AND INTEGRATIVE THERAPIES 
Another term used to describe the same group of CAM modalities is complementary and integrative 
therapies (CIT), which is more inclusive of health professions and alternatives beyond or in addition to medicine. 
Complementary and integrative therapies will be the term used for the remainder of this column and examples 
will be drawn from therapies where evidences of safety and efficacy exist. 
Use of CIT during pregnancy 
It is unclear how consumers get information about CIT during the perinatal period. On the basis of a recent 
survey, it would appear that television and trusted lay persons are major sources of health information during 
pregnancy.2 Despite barriers due to poverty, approximately 70% of Americans have Internet access, and nearly 
half of all Internet searches are related to health information.3 However, most of these searches are never 
discussed with a healthcare professional.4,5 The National Center for Complementary and Alternative Medicine 
Web site includes tips for consumers about talking to healthcare professionals about CIT.1 These tips include 
suggestions that consumers give their healthcare professionals a comprehensive picture of how they manage 
their health, including proactively discussing any CIT approaches that they may be using. 
The prevalence of the use of prenatal CIT is unknown, but based on a review of 24 publications on 
complementary therapies during pregnancy, it may be as high as 87%.6Complementary and integrative therapies 
used in the studies reviewed included herbs (ginger, raspberry leaf tea, Echinacea) and “acupuncture, 
acupressure, aromatherapy, massage, yoga, homeopathy, and chiropractic care.”6(p238) The authors of the review 
found that older, more affluent, and educated pregnant women, with more gestational discomforts, were more 
likely to use CIT. Although women regarded these alternative therapies as more safe and natural and having at 
least the same efficacy as pharmacologic treatments during pregnancy, only a small portion of the women had 
much knowledge of the therapy that they used. For example, in one of the studies reviewed,739% of Norwegian 
women studied used herbal preparations that had unknown safety for use during pregnancy or were considered 
harmful.6 
Concerns about CIT 
Sanderson and colleagues8 described the characteristics of alternative therapies likely to magnify consumer risk. 
These include ones for which the promoters (a) claim the therapy is a panacea; (b) deny responsibility for safety 
and/or discourage standard medical care, discounting the medical model; (c) foster psychological dependence in 
users; and (d) manifest no concern for the need to demonstrate therapeutic outcomes scientifically.8Other 
authors argue that although there are unscrupulous, self-serving producers and practitioners of unproven 
alternative therapies, the real question is whether the healthcare community is willing to follow where research 
findings about CIT lead.9 
Legal considerations 
The mostly noninvasive nature of CIT has led to the observation that CIT malpractice claims have been reported 
to represent less than 5% of all law suits.10,11 Nurses have the duty to stay current with the scientific literature 
on alternative therapies as well as include questions about CIT that their clients may be using. This preparation 
will help prevent accusations of fraud and/or recklessness on the part of the nurse recommending unproven 
therapies.11 If a professional nurse is planning to provide CIT, it is important to consult the state licensing 
statutes.11 This is recommended because if treatments with CIT are not considered a part of professional nursing 
practice in a particular state, a nurse who practices CIT could be disciplined for failing to conform to standards of 
acceptable practice, even without an adverse event. Fortunately, more than half of all state boards of nursing 
have explicit CIT guidelines.11 
As perinatal nurses provide health information to clients, it is imperative to think holistically. Nurses can gather 
important data that may otherwise be missed, and open further discussions by taking histories that include 
questions about which specific modalities of CIT a patient may be using. Upon discharge, it would be critical for 
nurses to address the CIT options that a client may be considering for future use. Most important, this 
information can help prevent potentially dangerous interactions between CIT compounds and/or supplements 
and pharmacologic therapies.12 Furthermore, if the nurse fails to react and provide accurate information when a 
patient discloses CIT use, the patient may interpret that the nurse approved the therapy. If harm occurs later, 
there could be a claim for failure to warn.11 
INFORMED CONSENT CONCERNS WITH CIT 
Sakala and Corry13 recently identified barriers to evidence-based maternity care. One such barrier was 
inadequate informed consent. Inadequacies exist in both the informed consent process and the woman's 
preparation to make decisions on the basis of sound information. Jordan and Murphy14 described informed 
consent as a “process of exchange between woman and healthcare provider to foster her ability to make the 
best decision about what to allow to be done to her.”14(p198) The general principles of informed consent can be 
applied to any perinatal procedure, test, or intervention including CIT. These authors also outlined the steps in 
the process of informed consent that will be used to shape the discussion that follows, including risk 
management, with examples pertinent to perinatal nursing. 
Health concern requiring treatment 
The diagnosis or health concern that requires treatment14 should be clearly discussed with the client. Often the 
exact diagnosis is unclear and CIT may be used while waiting for diagnostic testing to lessen symptoms. 
Alternatively, physiologic states and transitions, such as pregnancy symptom management, may be the primary 
goal of CIT. As previously noted, Adams and colleagues6 identified a variety of studies in which an array of CIT 
was used during pregnancy. 
Purpose of CIT approach 
The purpose of the CIT treatment14 approach should also be discussed with the client. It is crucial to distinguish 
how the CIT approach will be positioned within the entire plan of care. For example, clarification concerning 
how the therapy will complement or be integrated with the other approaches that are planned is essential. 
When a modality is being used to complement another, any interaction effect should be carefully considered. 
For example, probiotics can be used to successfully treat bacterial vaginosis in both pregnant and nonpregnant 
women.15 Since it is known that 10% to 15% of women do not achieve resolution to bacterial vaginosis following 
one course of antimicrobial treatment and that the recurrence rate is up to 80% for bacterial 
vaginosis,16 antibiotics alone do not appear to be the best or only option. These facts raise questions about the 
efficacy of current antibiotic therapy and the best approach to treatment and prevention. Furthermore, 
probiotics can reduce antibiotic-associated diarrhea and restore and/or maintain the normal gut flora during 
antibiotic treatment; therefore, they are often suggested as a complement to antibiotic therapies for a variety of 
infections. However, if probiotics and antibiotics are taken at the same time, the antibiotic may interfere with 
the efficacy of the probiotic. Therefore it is recommended that probiotic and antibiotic dosing be separated by 
at least 2 hours.17 
Interactive discussion of benefits and risks of CIT 
The benefits and risks of the CAM treatment approach14 should be outlined with the client. This is an area that 
may be the most challenging for perinatal nurses. The discussion needs to take place in a manner that allows for 
an interactive exchange where the woman is viewed as an essential partner who ultimately makes the 
decision.18 This approach is congruent with the American Nurses Association Code of Ethics. Philosophically, the 
code protects patient autonomy as the foundation for informed consent.19 Pregnant women reported wanting 
providers who were good listeners and collaborators in decision making.20,21 
Potential adverse effects specific to pregnancy 
Potential adverse effects and risks14 of any CIT approach should be discussed in detail. Concerns about adverse 
effects for the fetus were found to be the most common reason that women stopped CIT during pregnancy.6 It is 
tempting to assume that the use of over-the-counter therapies is benign, but it is well known that herbal 
therapies and supplements can have adverse effects.22 Similarly, acupuncture is widely recommended to treat 
and prevent a variety of health issues, but it is not completely risk-free. In a prospective observational study 
using a sample of 229 230 patients who received an average of 10 acupuncture treatments from German 
physicians, 8.6% reported at least 1 adverse event, most of which were minor.23 The most common of these 
were bleeding, hematoma, and pain.23 The authors developed and proposed an informational handout with a 
consent portion to facilitate the informed consent process for acupuncture patients in the future. Borup and 
colleagues24 conducted a controlled trial of 607 healthy laboring women at full term who were randomized to 
acupuncture, transcutaneous electrical nerve stimulation (TENS), or labor analgesics. No adverse effects were 
reported. Women in the acupuncture group used significantly fewer pharmacologic and invasive pain-relief 
measures than those in the TENS or standard analgesic groups. The authors identified that the acupuncturists’ 
education and experience were associated with the most optimal results and suggested that the best results 
might be achieved by a professional acupuncturist. 
Likelihood of success of CIT 
The likelihood that the CIT treatment will be successful14 should be discussed, including realistic goals and 
expectations of the time required to achieve the desired effects. Using a herbal CIT as an example, a recent 
Cochrane review25 found that St John's wort was equally effective for the treatment of major depression as 
standard antidepressants and had fewer adverse effects. In addition, St John's wort costs about one-fourth of 
the price of antidepressants.26 The duration of the studies in the Cochrane review ranged from 4 to 12 weeks 
and the efficacy was noted within that time.25 However, the time range to achieve therapeutic effect was not 
clearly stipulated in this review. This may be due to the poor study designs and lack of standardization among 
the 29 studies included. Furthermore, it is known that it can take as much as 8 to 12 weeks before the maximal 
therapeutic effects of antidepressants are experienced.27 Therefore, recommendations for St John's wort need 
to be tempered by the reality of the limitations in current research. It is also important to consider that the list 
of potential adverse effects and possible interactions for both the herbal and pharmacologic preparations are 
extensive.27 
Comprehensive explanation of varied approaches 
The range of treatment alternatives that are reasonably available, including benefits and risks, should also be 
shared with the patient.14 For example, if discussing the option of St John's wort for the treatment of major 
depression, the options of counseling and/or antidepressant therapies should be thoroughly discussed as well. 
Providing all the information provides a solid basis from which the woman can make an informed decision. 
Documentation of CIT discussion 
Documentation of informed consent is essential, including the patient's response to the suggestions made. 
When a client discloses the use of any CIT that does not have a solid scientific evidence base, it is important that 
the nurse alerts the patient to that fact and documents the conversation in the record.11 Jonas26 advised 
healthcare providers to follow 4 Ps when providing informed consent for CIT. They are (1) protect by promoting 
safety through the identification of any potentially harmful or toxic aspects; (2) permit by opening discussion of 
safety, efficacy, and costs of various therapies; (3) promote proven practices by making scientific evidence 
readily available to clients to increase their access; and (4) achieve partnership by actively cooperating with the 
client and CIT providers as part of the healthcare team. Following this approach could facilitate documentation. 
CONCLUSION 
Radzyminski11 stated that several CITs are recognized components of general nursing care and have been used 
for centuries (eg, nutrition, exercise, and massage). However, until the specifics of CITs are fully tested, it is 
inadvisable for nurses to recommend them to clients as if all aspects are evidence-based. More high-quality 
research on CIT approaches is needed to better inform these discussions. If nurses do not take the opportunity 
to be informed, other professional groups may take legal control of the therapies that had their origins in 
nursing practices. Remaining current with the ever-increasing evidence that exists about CIT may be the nurses’ 
best risk-management strategy of all. 
 
—Lisa Hanson, PhD, CNM, FACNM 
—Leona VandeVusse, PhD, CNM, FACNM 
College of Nursing, Marquette University, Milwaukee, Wisconsin 
 
REFERENCES 
1. National Institutes of Health: National Center for Complementary and Alternative Medicine. Americans spent 
$33.9 billion out-of-pocket on complementary and alternative 
medicine. http://nccam.nih.gov/news/2009/073009.htm. Accessed April 21, 2010. 
2. Declercq ER, Sakala C, Corry MP, Applebaum S. Listening to Mothers II: Report of the Second National U.S. 
Survey of Women's Childbearing Experiences. New York, NY: Childbirth Connection; 2006. 
3. Burns E. US search engine rankings. http://searchenginewatch.com/3626021. Published April 2007. Accessed 
May 20, 2010. 
4. Hesse BW, Nelson DE, Kreps GL, et al. Trust and sources of health information: the impact of the Internet and 
its implications for health care provider—findings from the First Health Information National Trends 
Survey. Arch Intern Med. 2005; 165:2618–2624. 
5. Ybarra ML, Suman M. Help seeking behavior and the Internet: a national survey. Int J Med Inform. 2006; 
75:29–41. 
6. Adams J, Lui C, Sibbritt D, et al. Women's use of complementary and alternative medicine: a critical review of 
the literature. Birth. 2009; 36:237–245. 
7. Nordeng H, Havnen GC. Use of herbal drugs in pregnancy: a survey among 400 Norwegian women. 
Pharmacoepidemiol Drug Saf. 2004; 13(6):371–380. 
8. Sanderson CR, Koczwara B, Currow DC. The “therapeutic footprint” of medical, complementary and alterative 
therapies and a doctor's duty to care. Med J Aust. 2006; 185:373–376. 
9. Epstein B. Reader's and author's responses to “Ethics and anomalous (alternative) medical practices.” 
MedGenMed. 2006; 8(3):69. 
10. Studdert DM, Eisenberg DM, Miller DA, Curto DA, Kaptchuk TJ, Brennan TA. Medical malpractice implications 
of alternative medicine. JAMA. 1998; 280(18):1610–1615. 
11. Radzyminski S. Legal parameters of alternative-complementary modalities in nursing practice. Nurs Clin 
North Am. 2007; 42:189–212. 
12. Denner SS. The evolving doctrine or informed consent for complementary and integrative therapy. Holist 
Nurs Pract. 2008; 22(1):37–43. 
13. Sakala C, Corry MP. Evidence-Based Maternity Care: What It Is and What It Can Achieve. New York, NY: 
Milbank Memorial Fund; 2008. 
14. Jordan RG, Murphy PA. Risk assessment and risk distortion: finding the balance. J Midwifery Womens Health. 
2009; 54:191–200. 
15. Abad CL, Safdar N. The role of Lactobacillus probiotics in the treatment or prevention of urogenital 
infections: a systematic review. J Chemother. 2009; 21:245–252. 
16. Senok AC, Verstraelen H, Temmerman M, Botta GA. Probiotics for the treatment of bacterial vaginosis. 
Cochrane Database Syst Rev. 2009;(4):CD006289. doi: 10.1002/14651858.CD006289.pub2. 
17. Williams NT. Clinical review: probiotics. Am J Health Syst Pharm. 2010; 67:449–458. 
18. Hanson L, VandeVusse L, Roberts J, Forristal A. A critical appraisal of guidelines for antenatal care: 
components of care and priorities in prenatal education. J Midwifery Womens Health. 2009; 54:458–
468. 
19. American Nurses Association. Code of Ethics for Nurses With Interpretive Statements. Washington, DC: 
American Nurses Association; 2001. 
20. Novick G. Women's experience of prenatal care: an integrative review. J Midwifery Womens Health. 2009; 
54:226–237. 
21. Armstrong TM, Pooley JA. Being pregnant: a qualitative study of women's lived experience of pregnancy. J 
Prenat Perinat Psychol Health. 2005; 20(1):4–24. 
22. Gardiner P, Phillips R, Shaughnessy AF. Herbal and dietary supplement drug interactions in patients with 
chronic illnesses. Am Fam Phys. 2008; 77(1):73–78. [published correction appears in Am Fam Physician. 
2008; 78(7):808] 
23. Witt CM, Pach D, Brinkhaus B, et al. Safety of acupuncture: results of a prospective observational study with 
229,230 patients and introduction of a medical information and consent form. Forsch Komplementmed. 
2009; 16:91–97. 
24. Borup L, Wurlitzer W, Hedegaard M, Kesmodel US, Hvidman L. Acupuncture as pain relief during delivery: a 
randomized controlled trial. Birth. 2009; 36(1):5–12. 
25. Linde K, Berner MM, Kriston L. St John's wort for major depression. Cochrane Database Syst Rev. 
2008;(4):CD000448. doi: 10.1002/14651858.CD000448.pub3. 
26. Jonas WB. Advising patients on the use of complementary and alternative medicine. Appl Psychophysiol 
Biofeedback. 2001; 26(3):205–214. 
27. King TL, Johnson R, Gamblian V. Mental health. In: King TL, Brucker MC, eds. Pharmacology for Women's 
Health. Sudbury, MA: Jones & Bartlett; 2011:750–772. 
 
© 2010 Lippincott Williams & Wilkins, Inc. 
 
 
 
